tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports
Want to see NGEN full AI Analyst Report?

NervGen Pharma (NGEN) Cash flow

87 Followers

NervGen Pharma Cash Flow

NGEN's free cash flow for Q4 2025 was $-10.13M. For the 2025 fiscal year, NGEN's free cash flow was decreased by $-7.80M and operating cash flow was $-10.13M. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Dec 22Dec 21
Operating Cash Flow
$ -19.50M$ -11.70M$ -8.52M$ -13.12M$ -6.54M
Investing Cash Flow
$ 100.93K$ 40.91K$ -104.77K$ -15.57K$ -35.64K
Financing Cash Flow
$ 23.76M$ 15.77M$ 578.16K$ 16.70M$ 15.51M
End Cash Position
$ 22.07M$ 12.00M$ 8.80M$ 16.56M$ 13.38M
Free Cash Flow
$ -19.50M$ -11.70M$ -8.53M$ -13.13M$ -6.54M
Currency in USD

NervGen Pharma Cash Flow